Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 6/20 | 0.71 |
| ▸ | NPC1 | O15118 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 3/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31136068 | 1.00 | CYP1A2 (1.00) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL14273063 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9AGAAFFAR1ALDH1A1 | |
| SCHEMBL2407154 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL2561504 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL8174562 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL8174554 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL14273049 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL7823640 | 0.85 | CYP1A2 (0.73) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL6230251 | 0.83 | CYP1A2 (0.71) | CYP1A2RAB9ANPC1POLBGAA | |
| SCHEMBL6231914 | 0.83 | CYP1A2 (0.71) | CYP1A2RAB9ANPC1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118782813-B | All-vanadium redox flow battery felt and preparation process thereof | 沈阳富莱碳纤维有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118782813-A | All-vanadium redox flow battery felt and preparation process thereof | 沈阳富莱碳纤维有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-107635676-B | Pretreatment method for electroless plating | 麦克德米德股份有限公司 | 2020-09-18 | — | — | CN | claimed |
| EP-3297772-A1 | METHOD OF PRETREATMENT FOR ELECTROLESS PLATING | MacDermid, Incorporated (US) | 2018-03-28 | — | — | EP | claimed |
| CN-107635676-A | The preprocess method of electroless plating | 麦克德米德股份有限公司 | 2018-01-26 | — | — | CN | claimed |
| US-20160348245-A1 | Method of Pretreatment for Electroless Plating | MACDERMID, INCORPORATED | 2016-12-01 | — | — | US | claimed |
| EP-1611092-A1 | PLEUROMUTILIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2006-01-04 | — | — | EP | claimed |
| WO-2004089886-A1 | PLEUROMUTILIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USES THEREOF | GLAXO GROUP LIMITED (GB) | 2004-10-21 | — | — | WO | claimed |
| CN-118782813-B | All-vanadium redox flow battery felt and preparation process thereof | 沈阳富莱碳纤维有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-118782813-A | All-vanadium redox flow battery felt and preparation process thereof | 沈阳富莱碳纤维有限公司 | 2024-10-15 | — | — | CN | disclosed |
| EP-3601216-B1 | SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-25 | — | — | EP | disclosed |
| EP-3601216-B1 | SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION | ARBUTUS BIOPHARMA CORP (CA) | 2023-10-25 | — | — | EP | disclosed |
| CN-107635676-B | Pretreatment method for electroless plating | 麦克德米德股份有限公司 | 2020-09-18 | — | — | CN | disclosed |
| EP-3601216-A1 | SUBSTITUTED DIHYDROINDENE-4-CARBOXAMIDES AND ANALOGS THEREOF, AND METHODS USING SAME | Arbutus Biopharma Corporation (CA) | 2020-02-05 | — | — | EP | disclosed |
| EP-0664806-A1 | HETEROCYCLIC CONDENSED BENZOIC ACID DERIVATIVES AS 5-HT 4? RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994008995-A1 | HETEROCYCLIC CONDENSED BENZOIC ACID DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-04-28 | — | — | WO | disclosed |
| US-4461911-A | FROM THIOGLYCOLIC ACID AND AN ARYLDIAZONIUM SALT, COPPER SALT, ACID MEDIUM | BAYER AKTIENGESELLSCHAFT (DE) | 1984-07-24 | — | — | US | disclosed |
| US-4185110-A | ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1980-01-22 | — | — | US | disclosed |
| US-3976780-A | Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES L'ILE-DE-FRANCE (FR) | 1976-08-24 | — | — | US | disclosed |
| US-3954748-A | ANTIEMETICS | SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE-FRANCE (FR) | 1976-05-04 | — | — | US | disclosed |